Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Does anyone know for how long Hargreaves Lansdown has been the biggest shareholder in Avacta? I was having a discussion with someone and they thought it was recent, but I’m not sure if it has been the case for a while.
They own 16 percent of the company.
That may be the spark Shorters like Jupiter need to get spooked investors to sell. Then they just flood the market with more stock for sale than there is demand using stock they have borrowed which means they can artificially affect the buy price.
The controlled drop is very obvious and personally gives me confidence in this share. I urge everyone to hold until these awful people have finished playing their games. And I pity anyone who is silly enough to sell because of their pathetic obviously misleading objections about the company.
It’s seems the price has been driven down today in spite of the interesting news that’s been posted today that says frozen validation is no longer necessary.
I think this has been done deliberately and there will be a 20p plus rise tomorrow.
Does anyone think that perhaps the sovereign test will be a test selected by the government and manufactured under licence and that then the owner of the test IP will be free to sell abroad to any country they like at their own higher price point. This way the government could have tests made at a lower price as they own the factories.
It would fit if this was going to be done with the Avacta test and explain why they don’t seem to be targeting the U.K. as priority over Europe.
Maybe because Avacta holders are smart enough to see the potential of a company with a USP that has many applications? Not that you should be going on about Avacta on this board
This from the Mologic news update on April 6th indicates their test which they were commencing scale up of at the time still uses N protein
Mologic’s easy-to-use, nasal swab test is intended for use by non-health professionals at home and accurately indicates the presence of SARS-CoV-2 nucleoprotein in approximately 20 minutes.
I find that interesting and no news update their since indicates they have changed course.
I’m not sure what’s going on as it is clear from Avacta that GAD are currently making the Avacta test so if that’s the case why are Mologic still plugging the n protein test on their website?
I think what a lot of people seem to forget when comparing the two companies tests is that they are working together and will both benefit significantly, why else would they collaborate?
I was reading Mologics news page and there are some sentences from past news articles that interest me
March 17th
Aptamer Group, the developer of diagnostic and therapeutic Optimer reagents, today announced a commercial partnership with Mologic, a leading developer and manufacturer of lateral flow and rapid diagnostic tests. The partnership will work towards CE marking of Aptamer Group’s AptaDx SARS-CoV-2 lateral flow rapid antigen test for professional use, to detect the SARS-CoV-2 spike protein antigen in anterior nasal swabs. Initial test analysis with laboratory samples has demonstrated excellent sensitivity being able to detect as little as 1000 virus particles per mL, with further clinical validation to support the CE marking to be performed at the Integrated COVID Hub North East in Newcastle, UK.
So could this mean that aptamers are not in the test being currently made at GAD and would seem that they are some way off marketing this new aptamer test?
It could also mean that Mologic decided not to make their test using aptamers and therefore the aptamer group decided to make their own test? That points to affimers being the reagent Mologic are using currently.
And this from the most recent news article
April 6
Mologic’s independently verified COVID-19 lateral flow technology combines all reagents in a unique design, and integrates reporting of results. The self-test can be used by a person without medical training at the point-of-need, including home, workplace, education and travel settings. Limit of detection and analytical sensitivity have been independently assessed by St Georges’ University of London, led by Dr Elisabetta Groppelli.
Does this sound like they are combining reagents for the new hybrid test collaboration with Avacta already, or is it saying that the Mologic test works with any reagent?
Apologies if I’m reading this wrong or it has been covered before.
It has been mentioned that the way porton down validate tests using frozen samples is not compatible with our test. Do you think they have been or will be prepared to change their methods or accept the independent validation we now have or are they digging their heels in? If so will it not be possible to use our test in the U.K. for some as simple as inflexible government bodies?